State Street’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

State Street’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.76M	Buy	+183,922	New	+$4.73M	﹤0.01%	2981
2024 Q3	–	Sell	-1,796	Closed	-$21.3K	–	4312
2024 Q2	$21.3K	Hold	1,796	–	–	﹤0.01%	4271
2024 Q1	$35K	Hold	1,796	–	–	﹤0.01%	4215
2023 Q4	$32.3K	Hold	1,796	–	–	﹤0.01%	4273
2023 Q3	$32.3K	Hold	1,796	–	–	﹤0.01%	4369
2023 Q2	$113K	Hold	1,796	–	–	﹤0.01%	4202
2023 Q1	$89.4K	Hold	1,796	–	–	﹤0.01%	4355
2022 Q4	$51.6K	Hold	1,796	–	–	﹤0.01%	4552
2022 Q3	$85K	Hold	1,796	–	–	﹤0.01%	4518
2022 Q2	$78K	Buy	1,796 +76	+4%	+$3.49K	﹤0.01%	4613
2022 Q1	$95K	Hold	1,720	–	–	﹤0.01%	4656
2021 Q4	$130K	Hold	1,720	–	–	﹤0.01%	4510
2021 Q3	$154K	Buy	+1,720	New	+$184K	﹤0.01%	4440

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

State Street's DMRA Position: Q1 2026 in Review

State Street opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 183,922 shares worth $4.76M. The stake represents ﹤0.01% of the portfolio and ranks #2981 among its holdings. This is a return to the name: State Street previously reported a position in DMRA as recently as Q2 2024.

State Street first reported a position in DMRA in Q3 2021 and has held it in 13 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

State Street held 183,922 shares of Damora Therapeutics, Inc. Ordinary Shares worth $4.76M as of Q1 2026.
Damora Therapeutics, Inc. Ordinary Shares was a new State Street position in Q1 2026.
Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2981 holding.
State Street first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q3 2021 and has held it in 13 quarters since.
65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.